Use of estrogen to modify the amount of serotonin transporter or its mrna
CA 2254339 A1 · Owner: Wilson, Helen · Inventors: Wilson, Helen; Mcqueen, Judith Katherine; Fink, George
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the use of oestrogen or a functional equivalent thereof to modify the amount of SERT or of SERT mRNA in order to combat disorders such as depressive disorders migraine or irritable bowel , syndrome. The invention provides medicaments comprising oestrogen or a functional equivalent to be administered in a pharmaceutical format. The invention also provides a method of selecting agents able to act as antidepressants based on the ability of the agents to affect or mimic the association of SERT and oestrogen.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 29, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 29, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 29, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.